Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jun-Ying Liu
Lamivudine Plus Adefovir Combination Therapy Versus Entecavir Monotherapy for Lamivudine-Resistant Chronic Hepatitis B: A Systematic Review and Meta-Analysis
Virology Journal
Virology
Infectious Diseases
Comparison of Sonographic Characteristics of Primary Thyroid Lymphoma and Anaplastic Thyroid Carcinoma
Journal of Thoracic Disease
Pulmonary
Respiratory Medicine
Related publications
Impact of Lamivudine Plus Adefovir Therapy in Chronic Hepatitis B Iranian Patients, Resistant to Lamivudine Treatment Alone, on Disease Inhibition: A Pilot Study
Open Journal of Gastroenterology
Erratum To: Add-On Adefovir Is Superior to a Switch to Entecavir as Rescue Therapy for Lamivudine-Resistant Chronic Hepatitis B
Digestive Diseases and Sciences
Physiology
Gastroenterology
Resistance to Adefovir Dipivoxil in Lamivudine Resistant Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil
Gut
Gastroenterology
Renal Dysfunction and Hypophosphatemia During Long-Term Lamivudine Plus Adefovir Dipivoxil Therapy in Patients With Chronic Hepatitis B
Journal of Gastroenterology
Gastroenterology
The Efficacy of Adefovir Dipivoxil Monotherapy and the Incidence of Genotypic Resistance to Adefovir Dipivoxil in Patients With Lamivudine-Resistant Chronic Hepatitis B Infection
The Korean Journal of Hepatology
Comparison of the Clinical Outcomes Between Antiviral-Naïve Patients Treated With Entecavir and Lamivudine-Resistant Patients Receiving Adefovir Add-On Lamivudine Combination Treatment
Clinical and molecular hepatology
Medicine
Hepatology
Molecular Biology
Evaluation of Long-Term Entecavir Treatment in Stable Chronic Hepatitis B Patients Switched From Lamivudine Therapy
Hepatology International
Hepatology
Immunomodulatory Effects of Combination Therapy With Bushen Formula Plus Entecavir for Chronic Hepatitis B Patients
Journal of Immunology Research
Medicine
Allergy
Immunology
The Effect of Prophylactic Lamivudine Plus Adefovir Therapy Compared With Lamivudine Alone in Preventing Hepatitis B Reactivation in Lymphoma Patients With High Baseline HBV DNA During Chemotherapy
PLoS ONE
Multidisciplinary
